ELAN Elanco Animal Health Incorporat

내부자 5명 장내 매수, 애널리스트 전망 상향 우세. 다만 공매도 잔고 12%.

종가$22.55
시가총액$118억
업종헬스케어
다음 실적 발표2026-11-06
매출 성장(최근 4분기)+12%
애널리스트 순상향률+21%
목표가 상승여력+34%
공매도 거래 비중57%
유명 투자자 보유1곳
1년 수익률+3.8%

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that pro

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목